…chemotherapy, surgery, radiotherapy, stem cell transplantation and anti-GD2 mAb treatment. A novel Phase II trial incorporating Hu14.18 into induction therapy and additionally, within post-consolidation therapy, demonstrated outstanding patient outcomes with…